180 related articles for article (PubMed ID: 16825911)
21. Helicobacter pylori infection and atrophic gastritis.
Ebule IA; Longdoh AN; Paloheimo IL
Afr Health Sci; 2013 Mar; 13(1):112-7. PubMed ID: 23658576
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups.
Knight T; Wyatt J; Wilson A; Greaves S; Newell D; Hengels K; Corlett M; Webb P; Forman D; Elder J
Br J Cancer; 1996 Mar; 73(6):819-24. PubMed ID: 8611388
[TBL] [Abstract][Full Text] [Related]
23. Helicobacter pylori infection, serum pepsinogens as markers of atrophic gastritis, and leukocyte telomere length: a population-based study.
Muhsen K; Sinnreich R; Merom D; Nassar H; Cohen D; Kark JD
Hum Genomics; 2019 Jul; 13(1):32. PubMed ID: 31331390
[TBL] [Abstract][Full Text] [Related]
24. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study.
Storskrubb T; Aro P; Ronkainen J; Sipponen P; Nyhlin H; Talley NJ; Engstrand L; Stolte M; Vieth M; Walker M; Agréus L
Scand J Gastroenterol; 2008; 43(12):1448-55. PubMed ID: 18663663
[TBL] [Abstract][Full Text] [Related]
25. Serum pepsinogens, gastrin-17 and Helicobacter pylori antibody in the residents of two cities in china with distinct mortality rates of gastric cancer.
Zheng KC; Aoki K; Li XQ; Lin SG; Wu BS; Zhong WL; Chen TH; Lin S; You JW; Su C
Tohoku J Exp Med; 2012 Dec; 228(4):289-94. PubMed ID: 23117263
[TBL] [Abstract][Full Text] [Related]
26. Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis.
Sitas F; Smallwood R; Jewell D; Millard PR; Newell DG; Meuwissen SG; Moses S; Zwiers A; Forman D
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):119-23. PubMed ID: 8467246
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of low vitamin B12 and high homocysteine in serum in an elderly male population: association with atrophic gastritis and Helicobacter pylori infection.
Sipponen P; Laxén F; Huotari K; Härkönen M
Scand J Gastroenterol; 2003 Dec; 38(12):1209-16. PubMed ID: 14750639
[TBL] [Abstract][Full Text] [Related]
28. Serological comparison of serum pepsinogen and anti-parietal cell antibody levels between Japanese and German patients.
Ito M; Haruma K; Kaya S; Kamada T; Kim S; Sasaki A; Sumii M; Tanaka S; Yoshihara M; Wagner S; Chayama K
Eur J Gastroenterol Hepatol; 2002 Feb; 14(2):123-7. PubMed ID: 11981335
[TBL] [Abstract][Full Text] [Related]
29. Chronic atrophic gastritis and Helicobacter pylori infection in primary biliary cirrhosis: a cross-sectional study with matching.
Floreani A; Biagini MR; Zappalà F; Farinati F; Plebani M; Rugge M; Surrenti C; Naccarato R
Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):13-7. PubMed ID: 9265572
[TBL] [Abstract][Full Text] [Related]
30. Relationship between Helicobacter pylori and atrophic gastritis.
Satoh K; Kimura K; Yoshida Y; Ota Y; Taniguchi Y; Kihira K; Kasano T; Takimoto T; Suzuki T; Seki M
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S85-8. PubMed ID: 7735942
[TBL] [Abstract][Full Text] [Related]
31. Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy.
Bodger K; Wyatt JI; Heatley RV
Helicobacter; 2001 Sep; 6(3):216-24. PubMed ID: 11683924
[TBL] [Abstract][Full Text] [Related]
32. Clinical meaning of pepsinogen test and Helicobacter pylori serology in the health check-up population in Korea.
Kim HY; Kim N; Kang JM; Park YS; Lee DH; Kim YR; Kim JS; Jung HC; Song IS
Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):606-12. PubMed ID: 19293719
[TBL] [Abstract][Full Text] [Related]
33. Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan.
Watanabe Y; Kurata JH; Mizuno S; Mukai M; Inokuchi H; Miki K; Ozasa K; Kawai K
Dig Dis Sci; 1997 Jul; 42(7):1383-7. PubMed ID: 9246033
[TBL] [Abstract][Full Text] [Related]
34. Is there a relationship between Helicobacter pylori and gastric autoimmunity?
Erdoğan A; Yilmaz U
Turk J Gastroenterol; 2011; 22(2):134-8. PubMed ID: 21796548
[TBL] [Abstract][Full Text] [Related]
35. [Helicobacter pylori and the development of atrophic gastritis].
Takahashi S; Igarashi H; Masubuchi N; Ishiyama N; Saito S; Aoyagi T; Itoh T; Hirata I
Nihon Rinsho; 1993 Dec; 51(12):3231-5. PubMed ID: 8283639
[TBL] [Abstract][Full Text] [Related]
36. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
[TBL] [Abstract][Full Text] [Related]
37. Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany.
Zhang Y; Weck MN; Schöttker B; Rothenbacher D; Brenner H
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):821-6. PubMed ID: 23456556
[TBL] [Abstract][Full Text] [Related]
38. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
39. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care.
Germaná B; Di Mario F; Cavallaro LG; Moussa AM; Lecis P; Liatoupolou S; Comparato G; Carloni C; Bertiato G; Battiestel M; Papa N; Aragona G; Cavestro GM; Iori V; Merli R; Bertolini S; Caruana P; Franzé A
Dig Liver Dis; 2005 Jul; 37(7):501-8. PubMed ID: 15975537
[TBL] [Abstract][Full Text] [Related]
40. Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality.
Tsugane S; Kabuto M; Imai H; Gey F; Tei Y; Hanaoka T; Sugano K; Watanabe S
Cancer Causes Control; 1993 Jul; 4(4):297-305. PubMed ID: 8347778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
